Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®GlobeNewsWire • 04/22/26
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/14/26
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific MeetingGlobeNewsWire • 04/13/26
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®'s LIBERTY® Endovascular Robotic SystemGlobeNewsWire • 03/26/26
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical JournalGlobeNewsWire • 03/24/26
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First TimeGlobeNewsWire • 03/10/26
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing RadiationGlobeNewsWire • 03/04/26
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical EventGlobeNewsWire • 03/03/26
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic SystemGlobeNewsWire • 02/24/26
Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation ConferenceGlobeNewsWire • 02/19/26
Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management ConferenceGlobeNewsWire • 02/12/26
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial AdoptionGlobeNewsWire • 02/05/26
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic SystemGlobeNewsWire • 11/26/25
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.GlobeNewsWire • 11/05/25
Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)Zacks Investment Research • 10/29/25
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual MeetingGlobeNewsWire • 10/16/25
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic SystemGlobeNewsWire • 10/14/25
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross ProceedsGlobeNewsWire • 10/07/25
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property PortfolioGlobeNewsWire • 10/01/25
All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to BuyZacks Investment Research • 09/26/25